Editas Medicine Announces First Quarter 2017 Results and Update – Nasdaq
|
Editas Medicine Announces First Quarter 2017 Results and Update
Nasdaq CAMBRIDGE, Mass., May 15, 2017 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today reported financial results for the first quarter ended March 31, 2017, and provided an update on recent … |
